Manasa Parakala

Manasa Parakala, Ph.D. has a diverse work experience in the field of pharmacology and neuroscience. Manasa is currently working at Sage Therapeutics as a Senior Scientist in In Vitro Pharmacology, a position they have held since November 2022. Prior to this role, they served as a Scientist II and Scientist I in In Vitro Pharmacology at the same company, starting in November 2020 and August 2019 respectively. Manasa also worked as an In Vitro Pharmacology Consultant for Sage Therapeutics from August 2018 to August 2019.

Before joining Sage Therapeutics, Manasa was a Postdoctoral Scholar at Tufts University from June 2018 to August 2018. Manasa completed their Ph.D. in Neuroscience at Tufts University, where their research focused on investigating neurosteroid modulation of GABAA receptors in the mouse hippocampus. During their Ph.D. studies, they collaborated with Sage Therapeutics to validate compounds in target-based assays for epilepsy and post-partum depression.

Manasa's earlier experiences include working as a Research Technician at the Moss Lab in the Neuroscience Department at Tufts University from June 2012 to August 2013, and as a Research Technician Co-op at the Reijmers Lab, Neuroscience Department at Tufts University from July 2011 to December 2011. Manasa also served as an Assistant Researcher Co-op at the Naarendorp Lab, Psychology Department at Northeastern University from July 2010 to December 2010, and as an Assistant Researcher at the Rosengaus Lab, Biology Department at Northeastern University from February 2009 to April 2009.

Overall, Manasa Parakala, Ph.D. has demonstrated their expertise in in vitro pharmacology and neuroscience through their various roles in academia and industry.

Manasa Parakala, Ph.D. completed their education in the field of neuroscience. Manasa obtained their Bachelor's degree in Science, specializing in Behavioral Neuroscience, from Northeastern University between 2008 and 2012. Later, they pursued further studies at Tufts University, where they earned their Doctor of Philosophy (Ph.D.) in Neuroscience from 2013 to 2018.